These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 12508160)

  • 41. Efficacy of cidofovir in a murine model of disseminated progressive vaccinia.
    Neyts J; Leyssen P; Verbeken E; De Clercq E
    Antimicrob Agents Chemother; 2004 Jun; 48(6):2267-73. PubMed ID: 15155231
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cidofovir use in acyclovir-resistant herpes infection.
    Martinez CM; Luks-Golger DB
    Ann Pharmacother; 1997 Dec; 31(12):1519-21. PubMed ID: 9416391
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Treatment of BK virus-associated hemorrhagic cystitis and simultaneous CMV reactivation with cidofovir.
    Held TK; Biel SS; Nitsche A; Kurth A; Chen S; Gelderblom HR; Siegert W
    Bone Marrow Transplant; 2000 Aug; 26(3):347-50. PubMed ID: 10967578
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Diagnostic and therapeutic dilemmas of a large scrotal lesion in an AIDS patient.
    Sparling JD; Norwood CW; Turiansky GW; Oster CN
    AIDS Read; 2001 Jan; 11(1):43-7. PubMed ID: 11215088
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Efficacy of oral active ether lipid analogs of cidofovir in a lethal mousepox model.
    Buller RM; Owens G; Schriewer J; Melman L; Beadle JR; Hostetler KY
    Virology; 2004 Jan; 318(2):474-81. PubMed ID: 14972516
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Interferon-alpha2b with protease inhibitor-based antiretroviral therapy in patients with AIDS-associated Kaposi sarcoma: an AIDS malignancy consortium phase I trial.
    Krown SE; Lee JY; Lin L; Fischl MA; Ambinder R; Von Roenn JH
    J Acquir Immune Defic Syndr; 2006 Feb; 41(2):149-53. PubMed ID: 16394845
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pilot study of oral valganciclovir therapy in patients with classic Kaposi sarcoma.
    Krown SE; Dittmer DP; Cesarman E
    J Infect Dis; 2011 Apr; 203(8):1082-6. PubMed ID: 21450998
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Local administration of cidofovir for human papilloma virus associated skin lesions in transplant recipients.
    Bonatti H; Aigner F; De Clercq E; Boesmueller C; Widschwendner A; Larcher C; Margreiter R; Schneeberger S
    Transpl Int; 2007 Mar; 20(3):238-46. PubMed ID: 17291217
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Management of Kaposi sarcoma: the role of interferon and thalidomide.
    Krown SE
    Curr Opin Oncol; 2001 Sep; 13(5):374-81. PubMed ID: 11555715
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Anti-KS activity still a mystery.
    Noonan D; Albini A
    Nat Med; 1998 Jul; 4(7):748. PubMed ID: 9662347
    [No Abstract]   [Full Text] [Related]  

  • 51. Therapeutic Perspectives in the Systemic Treatment of Kaposi's Sarcoma.
    Valantin MA; Royston L; Hentzien M; Jary A; Makinson A; Veyri M; Ronot-Bregigeon S; Isnard S; Palich R; Routy JP
    Cancers (Basel); 2022 Jan; 14(3):. PubMed ID: 35158752
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Recent Advances in Developing Treatments of Kaposi's Sarcoma Herpesvirus-Related Diseases.
    Naimo E; Zischke J; Schulz TF
    Viruses; 2021 Sep; 13(9):. PubMed ID: 34578378
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Human papillomavirus infection and ocular surface disease (Review).
    Chalkia AK; Bontzos G; Spandidos DA; Detorakis ET
    Int J Oncol; 2019 May; 54(5):1503-1510. PubMed ID: 30896784
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Kaposi's Sarcoma-Associated Herpesvirus (KSHV)-Associated Disease in the AIDS Patient: An Update.
    Dittmer DP; Damania B
    Cancer Treat Res; 2019; 177():63-80. PubMed ID: 30523621
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Viral Oncology: Molecular Biology and Pathogenesis.
    Mui UN; Haley CT; Tyring SK
    J Clin Med; 2017 Nov; 6(12):. PubMed ID: 29186062
    [TBL] [Abstract][Full Text] [Related]  

  • 56. HIV-associated Kaposi sarcoma and related diseases.
    Gonçalves PH; Uldrick TS; Yarchoan R
    AIDS; 2017 Sep; 31(14):1903-1916. PubMed ID: 28609402
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Brief Report: A Phase 1b/Pharmacokinetic Trial of PTC299, a Novel PostTranscriptional VEGF Inhibitor, for AIDS-Related Kaposi's Sarcoma: AIDS Malignancy Consortium Trial 059.
    Bender Ignacio RA; Lee JY; Rudek MA; Dittmer DP; Ambinder RF; Krown SE;
    J Acquir Immune Defic Syndr; 2016 May; 72(1):52-7. PubMed ID: 26689971
    [TBL] [Abstract][Full Text] [Related]  

  • 58. KSHV targeted therapy: an update on inhibitors of viral lytic replication.
    Coen N; Duraffour S; Snoeck R; Andrei G
    Viruses; 2014 Nov; 6(11):4731-59. PubMed ID: 25421895
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Viral profiling identifies multiple subtypes of Kaposi's sarcoma.
    Hosseinipour MC; Sweet KM; Xiong J; Namarika D; Mwafongo A; Nyirenda M; Chiwoko L; Kamwendo D; Hoffman I; Lee J; Phiri S; Vahrson W; Damania B; Dittmer DP
    mBio; 2014 Sep; 5(5):e01633-14. PubMed ID: 25249280
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Binding of the Kaposi's sarcoma-associated herpesvirus to the ephrin binding surface of the EphA2 receptor and its inhibition by a small molecule.
    Hahn AS; Desrosiers RC
    J Virol; 2014 Aug; 88(16):8724-34. PubMed ID: 24899181
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.